SCHEMBL6444482

SCHEMBL6444482

CC(C)(C)OC(=O)NC(Cc1ccccc1)C(O)C(O)C(Cc1ccccc1)NCc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.59
KLK5 Q9Y337 3/20 0.56
CTSS P25774 2/20 0.51
CTSK P43235 2/20 0.51
TRPM8 Q7Z2W7 1/20 0.51
CTSL P07711 1/20 0.51
CTSB P07858 1/20 0.51
ACE P12821 1/20 0.49
ALDH1A1 P00352 2/20 0.48
MEN1 O00255 1/20 0.48
LMNA P02545 1/20 0.48
PKM P14618 1/20 0.48
HPGD P15428 1/20 0.48
ALOX15 P16050 1/20 0.48
TSHR P16473 1/20 0.48
XBP1 P17861 1/20 0.48
HTT P42858 1/20 0.48
KMT2A Q03164 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6445261 0.92 KLK5 (0.63) ATMKLK5CTSSCTSKCTSL
SCHEMBL6446193 0.92 KLK5 (0.63) ATMKLK5CTSSCTSKCTSL
SCHEMBL6446777 0.92 KLK5 (0.63) ATMKLK5CTSSCTSKCTSL
SCHEMBL6445320 0.92 KLK5 (0.63) ATMKLK5CTSSCTSKCTSL
SCHEMBL6446779 0.92 KLK5 (0.63) ATMKLK5CTSSCTSKCTSL
SCHEMBL8534875 0.92 KLK5 (0.63) ATMKLK5CTSSCTSKCTSL
SCHEMBL6444857 0.92 KLK5 (0.63) ATMKLK5CTSSCTSKCTSL
SCHEMBL8532202 0.92 KLK5 (0.63) ATMKLK5CTSSCTSKCTSL
SCHEMBL7270592 0.90 KLK5 (0.63) ATMKLK5CTSSCTSKCTSL
SCHEMBL9848360 0.90 KLK5 (0.63) ATMKLK5CTSSCTSKCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839798-B1 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LAB (US) 2005-08-17 EP claimed
EP-0839798-A2 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LABORATORIES (US) 1998-05-06 EP claimed
EP-0839798-B1 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LAB (US) 2005-08-17 EP disclosed
EP-0839798-A2 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LABORATORIES (US) 1998-05-06 EP disclosed
US-5545750-A TREATING HUMAN IMMUNODEFICIENCY VIRUS ABBOTT LABORATORIES (US) 1996-08-13 US disclosed
EP-0402646-A1 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1990-12-19 EP disclosed